Volume | 49,713 |
|
|||||
News | - | ||||||
Day High | 1.3747 | Low High |
|||||
Day Low | 1.29 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Enlivex Therapeutics Ltd | ENLV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.30 | 1.29 | 1.3747 | 1.32 | 1.27 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
444 | 49,713 | $ 1.34 | $ 66,530 | - | 1.15 - 4.59 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:58:47 | formt | 800 | $ 1.36 | USD |
Enlivex Therapeutics Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
24.31M | 18.42M | - | 0 | -31.06M | -1.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Enlivex Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENLV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.32 | 1.56 | 1.2301 | 1.43 | 199,278 | 0.04 | 3.03% |
1 Month | 4.11 | 4.59 | 1.15 | 2.11 | 375,171 | -2.75 | -66.91% |
3 Months | 2.57 | 4.59 | 1.15 | 2.53 | 177,666 | -1.21 | -47.08% |
6 Months | 1.36 | 4.59 | 1.15 | 2.56 | 127,011 | 0.00 | 0.00% |
1 Year | 2.91 | 4.59 | 1.15 | 2.52 | 75,707 | -1.55 | -53.26% |
3 Years | 9.94 | 13.95 | 1.15 | 6.83 | 86,470 | -8.58 | -86.32% |
5 Years | 8.67 | 44.90 | 1.15 | 9.87 | 161,969 | -7.31 | -84.31% |
Enlivex Therapeutics Description
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. |